secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2023-09-19T23:59:59+00:00
Accession:  0001493152-23-033059
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics amends convertible notes: extends maturity to Aug 2024, increases principal
--------------------------------------------------------------------------------

- Entered amendment agreements for $2,161,316 of convertible notes, extending maturity to August 30, 2024.
- Principal increased to reflect implied 12% interest rate from amendment date through new maturity.
- Upon national exchange listing, notes automatically convert into Series A Convertible Preferred Stock.
- Company expects to enter similar amendments with remaining holders of $3,051,516 principal notes (as of June 30, 2023).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315223033059/0001493152-23-033059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315223033059/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-033059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer